Haiqing Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Haiqing Liu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Yanjun Tian
Affiliated Hospital of Jining Medical University (School of Clinical Medicine), Jining Medical University, Jining, Shandong, China
2 shared publications - Bingyuan Ji
School of Mental Health, Shandong Key Laboratory of Behavioral Medicine, Jining Medical University, No. 133 Hehua Road, Jining, PR China
1 shared publication Bo Bai
Institute of Neurobiology, Jining Medical University, Jining, China
1 shared publication- Bo Bai
Neurobiology Institute, Jining Medical University, Jining, Shandong 272067, P.R. China
1 shared publication - Guandong Yi
School of Nursing, Jining Medical University, Jining 272067, China
1 shared publication - Hai Lu
Fudan University, Jining Medical University, China
1 shared publication
Latest Publications
- Open Access
Role of STAT3 and NRF2 in Tumors: Potential Targets for Antitumor Therapy
Signal transducer and activator of transcription 3 (STAT3) and nuclear factor erythroid-derived 2-like 2 (NRF2, also known as NFE2L2), are two of the most complicated transcription regulators, which participate in a variety of physiological processes. Numerous studies have shown that they are overactivated in multiple types of tumors. Interestingly, STAT3 and NRF2 can also interact with each other to regulate tumor progression. Hence, these two important transcription factors are considered key targets for developing a new class of antitumor drugs. This review summarizes the pivotal roles of the two transcription regulators and their interactions in the tumor microenvironment to identify potential antitumor drug targets and, ultimately, improve patients’ health and survival.
Open AccessRole of STAT3 and NRF2 in Tumors: Potential Targets for Antitumor Therapy
Signal transducer and activator of transcription 3 (STAT3) and nuclear factor erythroid-derived 2-like 2 (NRF2, also known as NFE2L2), are two of the most complicated transcription regulators, which participate in a variety of physiological processes. Numerous studies have shown that they are overactivated in multiple types of tumors. Interestingly, STAT3 and NRF2 can also interact with each other to regulate tumor progression. Hence, these two important transcription factors are considered key targets for developing a new class of antitumor drugs. This review summarizes the pivotal roles of the two transcription regulators and their interactions in the tumor microenvironment to identify potential antitumor drug targets and, ultimately, improve patients’ health and survival.
- Open Access
- 3 March 2020
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 11, 75
The Protective Effects and Mechanisms of Apelin/APJ System on Ischemic Stroke: A Promising Therapeutic Target
The orphan receptor APJ and its endogenous ligand apelin, which are expressed in the brain, are the major components of the apelin/APJ system. Growing evidence shows that the apelin/APJ system plays a vital role in the pathophysiology of cerebral ischemic injury. Targeting the apelin/APJ system may have protective effects on cerebral ischemic injury. In this review, we sum up the latest research progress relating to the actions and therapeutic potential of the apelin/APJ system in ischemic stroke. An in-depth knowledge of the pathophysiological effects of the apelin/APJ system and the underlying mechanisms will help to develop novel therapeutic interventions for ischemic stroke.
- 3 March 2020
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 11, 75
Open AccessThe Protective Effects and Mechanisms of Apelin/APJ System on Ischemic Stroke: A Promising Therapeutic Target
The orphan receptor APJ and its endogenous ligand apelin, which are expressed in the brain, are the major components of the apelin/APJ system. Growing evidence shows that the apelin/APJ system plays a vital role in the pathophysiology of cerebral ischemic injury. Targeting the apelin/APJ system may have protective effects on cerebral ischemic injury. In this review, we sum up the latest research progress relating to the actions and therapeutic potential of the apelin/APJ system in ischemic stroke. An in-depth knowledge of the pathophysiological effects of the apelin/APJ system and the underlying mechanisms will help to develop novel therapeutic interventions for ischemic stroke.
- 1 November 2016
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1863 (11) , 2719-2738
Heterodimerization of the kappa opioid receptor and neurotensin receptor 1 contributes to a novel β-arrestin-2–biased pathway
- 1 November 2016
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1863 (11) , 2719-2738
Heterodimerization of the kappa opioid receptor and neurotensin receptor 1 contributes to a novel β-arrestin-2–biased pathway